CLINICAL_TRIALS
trial_result
· 2025-12-12
Clinical Trial Update: Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG) [Phase 2]
Summary
A completed Phase 2 clinical trial evaluating the efficacy and safety of different Mexidol dosages in patients with primary open-angle glaucoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmasoft | Conditions: Primary Open-Angle Glaucoma (POAG) | Phase 2 | Status: COMPLETED